Cleveland Clinic Lerner Research Institute Logo
Cleveland Clinic Lerner Research Institute Logo
  • About
  • Science
    • Laboratories
    • Office of Research Development
    • Clinical & Translational Research
      Participating in Research
    • Departments
      Biomedical Engineering Cancer Biology Cardiovascular & Metabolic Sciences Florida Research & Innovation Center Genomic Medicine Immunotherapy & Precision Immuno-Oncology
      Infection Biology Inflammation & Immunity Neurosciences Ophthalmic Research Quantitative Health Sciences Translational Hematology & Oncology Research
    • Centers & Programs
      Advanced Musculoskeletal Imaging Angiogenesis Center Cardiovascular Diagnostics & Prevention Computational Life Sciences Consortium for Pain Genitourinary Malignancies Research Genome Center
      Microbiome & Human Health Musculoskeletal Research Northern Ohio Alcohol Center Pathogen & Human Health Research Populations Health Research Quantitative Metabolic Research Therapeutics Discovery
  • Core Services
    • Ohio
      3D Printing Bioimage AnalysisBioRobotics & Mechanical Testing Cell Culture Cleveland Clinic BioRepository Computational Oncology Platform Computing Services Discovery Lab Electron Microscopy Electronics Engineering
      Flow CytometryGenomic Medicine Institute Biorepository Genomics Glassware Histology Hybridoma Immunohistochemistry Immunomonitoring Lab Instrument Refurbishing & Repair Laboratory Diagnostic
      Lerner Research Institute BioRepository Light MicroscopyMechanical Prototyping Microbial Culturing & Engineering Microbial Sequencing & Analytics Resources Media Preparation Molecular Biotechnology Nitinol Polymer Proteomics & Metabolomics Therapeutics Discovery
    • Florida
      Bioinformatics
      Flow Cytometry
      Imaging
  • Education & Training
    • Graduate Programs Molecular Medicine PhD Program Postdoctoral Program
      Research Intensive Summer Experience (RISE) Undergraduate & High School Programs
  • News
  • Careers
    • Faculty Positions Research Associate & Project Staff Postdoctoral Positions Technical & Administrative Engagement & Belonging
  • Donate
  • Contact
  • About
  • Science
    • Scientific Programs
    • Laboratories
    • Office of Research Development
    • Clinical & Translational Research
      Participating in Research
    • Departments
      Biomedical Engineering Cancer Biology Cardiovascular & Metabolic Sciences Florida Research & Innovation Center Genomic Medicine Immunotherapy & Precision Immuno-Oncology
      Infection Biology Inflammation & Immunity Neurosciences Ophthalmic Research Quantitative Health Sciences Translational Hematology & Oncology Research
    • Centers & Programs
      Advanced Musculoskeletal Imaging Angiogenesis Center Cardiovascular Diagnostics & Prevention Computational Life Sciences Consortium for Pain Genitourinary Malignancies Research Genome Center
      Microbiome & Human Health Musculoskeletal Research Northern Ohio Alcohol Center Pathogen & Human Health Research Populations Health Research Quantitative Metabolic Research Therapeutics Discovery
  • Core Services
    • All Cores
    • Ohio
      3D Printing Bioimage Analysis BioRobotics & Mechanical Testing Cell Culture Cleveland Clinic BioRepository Computational Oncology Platform Computing Services Discovery Lab Electron Microscopy Electronics Engineering >
      Flow CytometryGenomic Medicine Institute BiorepositoryGenomics Glassware Histology Hybridoma Immunohistochemistry Immunomonitoring Lab Instrument Refurbishing & Repair Laboratory Diagnostic
      Lerner Research Institute BioRepository Light MicroscopyMechanical Prototyping Microbial Culturing & Engineering Microbial Sequencing & Analytics Resources Media Preparation Molecular Biotechnology Nitinol Polymer Proteomics & Metabolomics Therapeutics Discovery
    • Florida
      Bioinformatics
      Flow Cytometry
      Imaging
  • Education & Training
    • Research Education & Training Center
    • Graduate Programs Molecular Medicine PhD Program Postdoctoral Program
      Research Intensive Summer Experience (RISE) Undergraduate & High School Programs
  • News
  • Careers
    • Faculty Positions Research Associate & Project Staff Postdoctoral Positions Technical & AdministrativeEngagement & Belonging
  • Donate
  • Contact
  • Search

Research News

❮News Dr. Jung Appointed to Betsy B. deWindt Endowed Chair in Cancer Biology

06/30/2021

Dr. Jung Appointed to Betsy B. deWindt Endowed Chair in Cancer Biology

Dr. Jung's endowed chair will support his research into infectious diseases and virus-induced cancers.

Jae Jung, PhD, chair of the Department of Cancer Biology and director of the Global Center for Pathogen Research & Human Health, has been named the Betsy B. deWindt Endowed Chair in Cancer Biology.

"At Cleveland Clinic, our robust clinical and research infrastructure enables us to develop innovative and novel approaches to uncover the mechanisms of infectious agents and virus-induced cancers and ultimately make a difference in the lives of our patients," says Dr. Jung. "I am excited and honored to continue this mission and be appointed to the Betsy B. deWindt Endowed Chair in Cancer Biology."

As chair of the Department of Cancer Biology, Dr. Jung leads a team of accomplished researchers in a wide range of cancer research areas including prostate cancer, glioblastoma and cancer stem cells. His cancer research focuses on virus-induced cancers, including Kaposi's sarcoma, the most common tumor in patients with AIDS. Dr. Jung was awarded the prestigious Outstanding Investigator Award by the National Cancer Institute in 2016 for his work in this area.

In addition to cancer research, Dr. Jung is an internationally-renowned expert in virology and serves as the director of Cleveland Clinic's Global Center for Pathogen Research & Human Health, where he leads virology, immunology and oncology researchers working to make laboratory discoveries about how pathogens spread and cause disease. 

As part of the Global Center, Dr. Jung has several research projects related to coronaviruses, including vaccine and drug development. He developed one of the first preclinical models to study SARS-CoV-2 infection and transmission to lead to the development of a COVID-19 vaccine candidate. His vaccine work utilizes nanoparticles that compel the coronavirus to use its own surface protein to produce antibodies that block viral infection. The hope is that this approach will have fewer side effects than other vaccines, especially among the older population that is particularly susceptible to COVID-19. 

Featured Experts
Jae Jung Headshot
Jae
Jung, PhD
News Category
news
Related News
$2.8M Grant Awarded to Develop Vaccine to Counter Emerging Tick-Borne VirusCleveland Clinic Receives $2.9 Million for Additional Research on Emerging Tick-borne Virus PathogenCharacterizing Patient Immune Responses to Emerging Tick-borne Virus

Research areas

Cancer Biology

Want To Support Ground-Breaking Research at Cleveland Clinic?

Discover how you can help Cleveland Clinic save lives and continue to lead the transformation of healthcare.

Give to Cleveland Clinic

Subscribe to get the latest research news in your inbox.

About Lerner

About Us Careers Contact Us Donate People Directory

Science

Clinical & Translational Research Core Services Departments, Centers & Programs Laboratories Research News

Education & Training

Graduate Programs Molecular Medicine PhD Program Postdoctoral Program RISE Program Undergraduate & High School Programs

Site Information & Policies

Search Site Site Map Privacy Policy Social Media Policy

9500 Euclid Avenue, Cleveland, Ohio 44195 | © 2025 Lerner Research Institute